{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:26:21Z","timestamp":1779207981858,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002329","name":"Bundesamt f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40263-025-01189-1","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T09:26:13Z","timestamp":1749288373000},"page":"807-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetics and Pharmacodynamics of Intranasal Diacetylmorphine in Heroin-Assisted Treatment\u00a0for Severe Opioid Use Disorder"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0280-4629","authenticated-orcid":false,"given":"Adrian","family":"Guessoum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3650-3549","authenticated-orcid":false,"given":"Severin B.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-1195","authenticated-orcid":false,"given":"Maximilian","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4720-8402","authenticated-orcid":false,"given":"Jean Nicolas","family":"Westenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Klemperer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1552-5822","authenticated-orcid":false,"given":"Kenneth M.","family":"D\u00fcrsteler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-9659","authenticated-orcid":false,"given":"Matthias E.","family":"Liechti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-2671","authenticated-orcid":false,"given":"Jan","family":"Thomann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0874-4875","authenticated-orcid":false,"given":"Dino","family":"Luethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7811-3932","authenticated-orcid":false,"given":"Urs","family":"Duthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3088-0331","authenticated-orcid":false,"given":"Marc","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"key":"1189_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/add.14442","volume":"114","author":"C Nordt","year":"2019","unstructured":"Nordt C, Vogel M, Dey M, Moldovanyi A, Beck T, Berthel T, et al. One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years. Addiction (Abingdon, England). 2019;114:103\u201311. https:\/\/doi.org\/10.1111\/add.14442.","journal-title":"Addiction (Abingdon, England)"},{"key":"1189_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12954-021-00584-3","volume":"18","author":"M Meyer","year":"2021","unstructured":"Meyer M, Eichenberger R, Strasser J, D\u00fcrsteler KM, Vogel M. One prick and then it\u2019s done: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment. Harm Reduct J. 2021;18:1\u201310. https:\/\/doi.org\/10.1186\/S12954-021-00584-3.","journal-title":"Harm Reduct J"},{"key":"1189_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12954-023-00731-Y\/TABLES\/4","volume":"20","author":"M Vogel","year":"2023","unstructured":"Vogel M, Meyer M, Westenberg JN, Kormann A, Simon O, Salim Hassan Fadlelseed R, et al. Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study. Harm Reduct J. 2023;20:1\u20138. https:\/\/doi.org\/10.1186\/S12954-023-00731-Y\/TABLES\/4.","journal-title":"Harm Reduct J"},{"key":"1189_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-023-00367-0","volume":"18","author":"JN Westenberg","year":"2023","unstructured":"Westenberg JN, Meyer M, Strasser J, Krausz M, D\u00fcrsteler KM, Falcato L, et al. Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study. Addict Sci Clin Pract. 2023;18:1\u20138. https:\/\/doi.org\/10.1186\/s13722-023-00367-0.","journal-title":"Addict Sci Clin Pract"},{"key":"1189_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-022-00644-2","volume":"19","author":"M Meyer","year":"2022","unstructured":"Meyer M, Westenberg JN, Strasser J, D\u00fcrsteler KM, Lang UE, Krausz M, et al. Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment. Harm Reduc J. 2022;19:1\u20136. https:\/\/doi.org\/10.1186\/s12954-022-00644-2.","journal-title":"Harm Reduc J."},{"key":"1189_CR6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1046\/j.1365-2044.2000.01373.x","volume":"55","author":"A Hallett","year":"2000","unstructured":"Hallett A, O\u2019Higgins F, Francis V, Cook TM. Patient-controlled intranasal diamorphine for postoperative pain. Anaesthesia. 2000;55:532\u20135329. https:\/\/doi.org\/10.1046\/j.1365-2044.2000.01373.x.","journal-title":"Anaesthesia"},{"key":"1189_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1365-2044.2002.02263.x","volume":"57","author":"M Ward","year":"2002","unstructured":"Ward M, Minto G, Alexander-Williams JM. A comparison of patient-controlled analgesia administered by the intravenous or intranasal route during the early postoperative period. Anaesthesia. 2002;57:49\u201352. https:\/\/doi.org\/10.1046\/j.1365-2044.2002.02263.x.","journal-title":"Anaesthesia"},{"key":"1189_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/jat\/17.6.327","volume":"17","author":"EJ Cone","year":"1993","unstructured":"Cone EJ, Holicky BA, Grant TM, Darwin WD, Goldberger BA. Pharmacokinetics and pharmacodynamics of intranasal \u201csnorted\u201d heroin. J Anal Toxicol. 1993;17:327\u201337. https:\/\/doi.org\/10.1093\/jat\/17.6.327.","journal-title":"J Anal Toxicol"},{"key":"1189_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/jat\/21.2.105","volume":"21","author":"G Skopp","year":"1997","unstructured":"Skopp G, Ganssmann B, Cone EJ, Aderjan R, Skoppl G, Ganssmann B, et al. Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration. J Anal Toxicol. 1997;21:105\u201311. https:\/\/doi.org\/10.1093\/jat\/21.2.105.","journal-title":"J Anal Toxicol"},{"key":"1189_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/00008877-199712000-00002","volume":"8","author":"SD Comer","year":"1997","unstructured":"Comer SD, Collins ED, Fischman MW. Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol. 1997;8:677\u201390. https:\/\/doi.org\/10.1097\/00008877-199712000-00002.","journal-title":"Behav Pharmacol"},{"key":"1189_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s002130050956","volume":"143","author":"SD Comer","year":"1999","unstructured":"Comer SD, Collins ED, MacArthur RB, Fischman MW. Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology. 1999;143:327\u201338. https:\/\/doi.org\/10.1007\/s002130050956.","journal-title":"Psychopharmacology"},{"key":"1189_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000090428","volume":"12","author":"TB Mitchell","year":"2006","unstructured":"Mitchell TB, Lintzeris N, Bond A, Strang J. Feasibility and acceptability of an intranasal diamorphine spray as an alternative to injectable diamorphine for maintenance treatment. Eur Addict Res. 2006;12:91\u20135. https:\/\/doi.org\/10.1159\/000090428.","journal-title":"Eur Addict Res"},{"key":"1189_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2165\/00003088-200342060-00001","volume":"42","author":"JM Kendall","year":"2003","unstructured":"Kendall JM, Latter VS. Intranasal diamorphine as an alternative to intramuscular morphine: pharmacokinetic and pharmacodynamic aspects. Clin Pharmacokinet. 2003;42:501\u201313. https:\/\/doi.org\/10.2165\/00003088-200342060-00001.","journal-title":"Clin Pharmacokinet"},{"key":"1189_CR14","unstructured":"Swiss Federal Council; Verordnung \u00fcber Bet\u00e4ubungsmittelsucht und andere suchtbedingte St\u00f6rungen - Art. 10: Aufnahmekriterien. 2011. Accessed 2024 Dec 2. https:\/\/www.fedlex.admin.ch\/eli\/cc\/2011\/364\/de#art_10"},{"key":"1189_CR15","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0022-3565(25)39261-X","volume":"243","author":"KL Preston","year":"1987","unstructured":"Preston KL, Bigelow GE, Bickel W, Liebson IA. Three-choice drug discrimination in opioid-dependent humans: hydromorphine, naloxone and saline. J Pharmacol Exp Ther. 1987;243:1002\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"1189_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","volume":"15","author":"M Gossop","year":"1990","unstructured":"Gossop M. The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav. 1990;15:487\u201390. https:\/\/doi.org\/10.1016\/0306-4603(90)90036-W.","journal-title":"Addict Behav"},{"key":"1189_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCHROMB.2024.124104","volume":"1237","author":"J Thomann","year":"2024","unstructured":"Thomann J, Vogt SB, Guessoum A, Meyer M, Vogel M, Liechti ME, et al. Development and validation of an LC-MS\/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma. J Chromatogr B. 2024;1237: 124104. https:\/\/doi.org\/10.1016\/J.JCHROMB.2024.124104.","journal-title":"J Chromatogr B"},{"key":"1189_CR18","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/jps.1131","volume":"90","author":"RT Penson","year":"2001","unstructured":"Penson RT, Joel SP, Clark S, Gloyne A, Slevin ML. Limited phase I study of morphine-3-glucuronide. J Pharm Sci. 2001;90:1810\u20136. https:\/\/doi.org\/10.1002\/jps.1131.","journal-title":"J Pharm Sci"},{"key":"1189_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1067\/MCP.2003.5","volume":"73","author":"C Skarke","year":"2003","unstructured":"Skarke C, Darimont J, Schmidt H, Geisslinger G, L\u00f6tsch J. Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clin Pharmacol Ther. 2003;73:107\u201321. https:\/\/doi.org\/10.1067\/MCP.2003.5.","journal-title":"Clin Pharmacol Ther"},{"key":"1189_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0006-2952(01)00689-X","volume":"62","author":"DE Selley","year":"2001","unstructured":"Selley DE, Cao CC, Sexton T, Schwegel JA, Martin TJ, Childers SR. mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem Pharmacol. 2001;62:447\u201355. https:\/\/doi.org\/10.1016\/S0006-2952(01)00689-X.","journal-title":"Biochem Pharmacol"},{"key":"1189_CR21","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1097\/00000542-199712000-00014","volume":"87","author":"J L\u00f6tsch","year":"1997","unstructured":"L\u00f6tsch J, Kobal G, Stockmann A, Brune K, Geisslinger G. Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology. 1997;87:1348\u201358. https:\/\/doi.org\/10.1097\/00000542-199712000-00014.","journal-title":"Anesthesiology"},{"key":"1189_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.18433\/J3GP53","volume":"17","author":"C Louizos","year":"2014","unstructured":"Louizos C, Y\u00e1\u00f1ez JA, Forrest ML, Davies NM. Understanding the hysteresis loop conundrum in pharmacokinetic\/pharmacodynamic relationships. J Pharm Pharm Sci. 2014;17:34\u201391. https:\/\/doi.org\/10.18433\/J3GP53.","journal-title":"J Pharm Pharm Sci"},{"key":"1189_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41398-023-02406-5","volume":"13","author":"MS Milella","year":"2023","unstructured":"Milella MS, D\u2019Ottavio G, De Pirro S, Barra M, Caprioli D, Badiani A. Heroin and its metabolites: relevance to heroin use disorder. Transl Psychiatry. 2023;13:120. https:\/\/doi.org\/10.1038\/s41398-023-02406-5.","journal-title":"Transl Psychiatry"},{"key":"1189_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0009-9236(03)00199-1","volume":"74","author":"F Girardin","year":"2003","unstructured":"Girardin F, Rentsch KM, Schwab M-A, Maggiorini M, Pauli-Magnus C, Kullak-Ublick GA, et al. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts. Clin Pharmacol Ther. 2003;74:341\u201352. https:\/\/doi.org\/10.1016\/S0009-9236(03)00199-1.","journal-title":"Clin Pharmacol Ther"},{"key":"1189_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/157488406775268219","volume":"1","author":"EJ Rook","year":"2006","unstructured":"Rook EJ, Huitema ADR, van den Brink W, van Ree JM, Beijnen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol. 2006;1:109\u201318. https:\/\/doi.org\/10.2174\/157488406775268219.","journal-title":"Curr Clin Pharmacol"},{"key":"1189_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12954-023-00758-1\/FIGURES\/3","volume":"20","author":"ON Kavanagh","year":"2023","unstructured":"Kavanagh ON, Machado TC. A method of diamorphine (heroin) administration for harm reduction. Harm Reduct J. 2023;20:1\u20136. https:\/\/doi.org\/10.1186\/S12954-023-00758-1\/FIGURES\/3.","journal-title":"Harm Reduct J"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01189-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01189-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01189-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:40:03Z","timestamp":1757187603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01189-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01189-1","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"19 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee for Northwest and Central Switzerland (project ID: 2020-00354) approved the study, which was performed in accordance with the Sixth Revision of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This study was funded by the Swiss Federal Office of Public Health. The funding covered costs related to laboratory analyses, equipment and participant compensation. The funding source had no role in the design of the study, data collection, analysis, interpretation of the data, or the writing of the manuscript.\u00a0Open access funding was provided by the University of Basel as part of an institutional agreement with Springer Nature.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The data that support the findings are available from the corresponding author upon reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"A.G. and M.V. conceived the study. A.G., S.B.V., M.M., and B.K. carried out the clinical procedures and blood sampling. S.B.V., J.T., D.L., and U.D. were responsible for pharmacokinetic analyses. M.V., K.M.D., and M.E.L. supervised the project. M.V. was responsible for funding acquisition. A.G., J.N.W., and S.B.V. wrote the initial manuscript draft. All authors were involved in revising the manuscript. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}